Sinclair Pharma PLC - Holding(s) in Company

RNS Number : 3159E

Sinclair Pharma PLC

17 October 2018

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)ⁱ

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedⁱⁱ:			Sinclair Pharma PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments						X
An event changing the breakdown of voting rights
Other (please specify)ⁱⁱⁱ:
3. Details of person subject to the notification obligation^iv
Name			Weiss Asset Management LP
City and country of registered office (if applicable)			Wilmington, Delaware, USA
4. Full name of shareholder(s) (if different from 3.)^v
Name			Brookdale International Partners, L.P., Brookdale Global Opportunity Fund
City and country of registered office (if applicable)			Brookdale International Partners, L.P.: New York, NY, USA Brookdale Global Opportunity Fund: Grand Cayman, Cayman Islands
5. Date on which the threshold was crossed or reached^vi:			Oct-16-2018
6. Date on which issuer notified (DD/MM/YYYY):			Oct-16-2018
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights of issuer^vii
Resulting situation on the date on which threshold was crossed or reached	0.0 %	12.11 %		12.11 %	503,768,952
Position of previous notification (if applicable)	0.0 %	5.20 %		5.20 %

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached^viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights^ix					% of voting rights
		Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)			Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)



SUBTOTAL 8. A

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument		Expiration date^x	Exercise/ Conversion Period^xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights



			SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration date^x		Exercise/ Conversion Period ^xi		Physical or cash settlement^xii			Number of voting rights	% of voting rights
CFD	N/A		N/A		Cash Settlement			60,997,322	12.11 %


					SUBTOTAL 8.B.2			60,997,322	12.11 %

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer^xiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity^xiv (please add additional rows as necessary)				X
Name^xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Weiss Asset Management LP
Brookdale International Partners, L.P.		8.11%	8.11%

Weiss Asset Management LP
Brookdale Global Opportunity Fund		Below 5.0%	Below 5.0%

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information^xvi
Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P.

Place of completion	Boston, USA
Date of completion	Oct-16-2018

Annex: Notification of major holdings (to be filed with the FCA only)

A: Identity of the person subject to the notification obligation
Full name (including legal form for legal entities)		Weiss Asset Management LP
Contact address (registered office for legal entities)		222 Berkeley St., 16th Floor, Boston, MA 02116, USA
E-Mail		compliance@weissasset.com
Phone number / Fax number		+1-617-778-7780
Other useful information (at least legal representative for legal persons)		Attn: Georgiy Nikitin

B: Identity of the notifier, if applicable
Full name
Contact address
E-Mail
Phone number / Fax number
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

Please send the completed form together with this annex to the FCA at the following email

address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word format if possible.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLMRBRTMBMBMJP ]]>